Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Multiples aberrant phenotypes in multiple myeloma patient expressing CD56(-), CD28(+),CD19(+).

Literature DB >> 23049389

Multiples aberrant phenotypes in multiple myeloma patient expressing CD56(-), CD28(+),CD19(+).

Luiz Arthur Calheiros Leite¹, Daniela Márcia Bahia Kerbauy, Elisa Kimura, Mihoko Yamamoto.

Abstract

Entities: Chemical Disease Gene Mutation Species

Year: 2012 PMID： 23049389 PMCID： PMC3459618 DOI： 10.5581/1516-8484.20120019

Source DB: PubMed Journal: Rev Bras Hematol Hemoter ISSN： 1516-8484

Keyword Cloud
References

× No keyword cloud information.

7 in total

1. Endogenous CD28 expressed on myeloma cells up-regulates interleukin-8 production: implications for multiple myeloma progression.

Authors: V S Shapiro; M N Mollenauer; A Weiss
Journal: Blood Date: 2001-07-01 Impact factor: 22.113

2. Plasma cells in multiple myeloma express a natural killer cell-associated antigen: CD56 (NKH-1; Leu-19).

Authors: B Van Camp; B G Durie; C Spier; M De Waele; I Van Riet; E Vela; Y Frutiger; L Richter; T M Grogan
Journal: Blood Date: 1990-07-15 Impact factor: 22.113

3. Genetic abnormalities and patterns of antigenic expression in multiple myeloma.

Authors: Gema Mateo; Mariana Castellanos; Ana Rasillo; Norma C Gutiérrez; Ma Angeles Montalbán; Ma Luisa Martín; Jesús Ma Hernández; Ma Consuelo López-Berges; Laura Montejano; Joan Bladé; Ma Victoria Mateos; Anna Sureda; Javier de la Rubia; Joaquín Díaz-Mediavilla; Atanasio Pandiella; Juan José Lahuerta; Alberto Orfao; Jesús F San Miguel
Journal: Clin Cancer Res Date: 2005-05-15 Impact factor: 12.531

Multiples aberrant phenotypes in multiple myeloma patient expressing CD56(-), CD28(+),CD19(+).

1. Endogenous CD28 expressed on myeloma cells up-regulates interleukin-8 production: implications for multiple myeloma progression.

2. Plasma cells in multiple myeloma express a natural killer cell-associated antigen: CD56 (NKH-1; Leu-19).

3. Genetic abnormalities and patterns of antigenic expression in multiple myeloma.

4. Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma.

Review 5. Heterogeneity in the multiple myeloma tumor clone.

Review 6. Prognostic significance of surface markers expressed in multiple myeloma: CD56 and other antigens.

Review 7. Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma.